Esophageal Implant Market to Reach USD 280.2 Million by 2033, Growing at a 6.7% CAGR

Esophageal Implant Market
Esophageal Implant Market

The global esophageal implant market is poised for significant expansion over the next decade. According to recent estimates, the market is expected to reach a valuation of USD 147.0 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2033. By the end of 2033, the market value is anticipated to exceed USD 280.2 million.

This growth is driven by advancements in medical technology, increasing prevalence of esophageal conditions, and a growing focus on improving patient outcomes. As the demand for minimally invasive solutions rises, esophageal implants are gaining traction as a preferred treatment option.

Similarly, the adoption of Esophageal Implants will be driven by technological breakthroughs and product innovation. Improved attributes, such as improved biocompatibility, durability, ease of insertion, and patient comfort, tend to increase market share and boost sales.

Compliance with regulatory requirements and regulatory approvals are required for the commercialization and selling of Esophageal Implants. Companies that have gotten all of the relevant certifications and approvals have a competitive advantage and better sales.

Reimbursement policies and coverage for Esophageal Implants have an impact on sales since they affect patients’ access to and affordability of these devices. Favourable reimbursement regulations can boost Esophageal Implant acceptance and sales.

Because of variances in healthcare infrastructure, disease incidence, economic variables, and cultural factors, demand for Esophageal Implants varies among areas and countries. Companies may need to adjust their sales strategy to target various regional areas.

Key Takeaways from the Esophageal Implant Market:

  • Global sales of Esophageal Implants are expected to surge at 6.7% CAGR through 2033.
  • Based on the product, esophageal stents segment is forecast to progress at 6.0% CAGR from 2023 to 2033.
  • By application, the gastroesophageal reflux disease (GERD) segment is poised to exhibit 7.4% CAGR through 2033.
  • By end-use, the hospital segment is anticipated to expand at a CAGR of 7.1% over the forecast duration.
  • The United States’ Esophageal Implant market value is likely to reach US$ 105.2 million by 2033.
  • The United Kingdom’s Esophageal Implant industry is estimated to reach a valuation of US$ 14.11 million by 2033.
  • Esophageal Implant demand in China is expected to increase at 8.6% CAGR through 2033.
  • Japan’s market is predicted to reach a valuation of US$ 4.4 million by 2033.
  • South Korea’s Esophageal Implant industry is poised to exhibit a 6.9% CAGR during the forecast period.

“Rising prevalence of esophageal disorders globally will create high demand for Esophageal Implants during the assessment period. To gain profits, manufacturers should focus on markets with favorable regulatory environments and operational guidelines.” – says a lead analyst at Future Market Insights (FMI)

Recent developments:

  • In 2020, Olympus started the commercial launch of the HANAROSTENT Esophagus TTS Stent.

More Insights Available:

Future Market Insights (FMI), in its new offering, presents an unbiased analysis of the Esophageal Implant market presenting historical data (2017 to 2022) and forecast statistics for the period from 2023 to 2033.

The study reveals future market projections based on the product (esophageal stents, magnetic sphincter augmentation (MSA) devices, injectable bulking agents, and artificial esophageal valves), application (gastroesophageal reflux disease (GERD), esophageal strictures, esophageal fistulas, esophageal defects, and weakened esophageal sphincters), and end-user (hospitals, ambulatory surgical centers, specialty clinics, academic & research institutions, and weakened esophageal sphincters) across various regions.

A Old Full Report Analysis Click Here

Esophageal Implant Market Segmentation

By Product:

  • Esophageal Stents
    • Self-Expandable Metal Stents (SEMS)
    • Polymer Stents
    • Biodegradable Stents
    • Hybrid Stents
  • Magnetic Sphincter Augmentation (MSA) Devices
  • Injectable Bulking Agents
  • Artificial Esophageal Valves
    • Endoscopic Esophageal Valves
    • Prosthetic Esophageal Valves

By Application:

  • Gastroesophageal Reflux Disease (GERD)
  • Esophageal Strictures
  • Esophageal Fistulas
  • Esophageal Defects
  • Weakened Esophageal Sphincters

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Speciality Clinics
  • Academic & Research Institutions
  • Weakened Esophageal Sphincters

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *